134 related articles for article (PubMed ID: 34116425)
1. Interactions of copper and copper chelate compounds with the amyloid beta peptide: An investigation into electrochemistry, reactive oxygen species and peptide aggregation.
Crnich E; Lullo R; Tabaka A; Havens MA; Kissel DS
J Inorg Biochem; 2021 Sep; 222():111493. PubMed ID: 34116425
[TBL] [Abstract][Full Text] [Related]
2. On the generation of OH(·) radical species from H2O2 by Cu(I) amyloid beta peptide model complexes: a DFT investigation.
Prosdocimi T; De Gioia L; Zampella G; Bertini L
J Biol Inorg Chem; 2016 Apr; 21(2):197-212. PubMed ID: 26711660
[TBL] [Abstract][Full Text] [Related]
3. Amyloid beta-Cu2+ complexes in both monomeric and fibrillar forms do not generate H2O2 catalytically but quench hydroxyl radicals.
Nadal RC; Rigby SE; Viles JH
Biochemistry; 2008 Nov; 47(44):11653-64. PubMed ID: 18847222
[TBL] [Abstract][Full Text] [Related]
4. Copper(I) Chelators for Alzheimer's Disease.
Opare SKA; Rauk A
J Phys Chem B; 2017 Dec; 121(50):11304-11310. PubMed ID: 29172520
[TBL] [Abstract][Full Text] [Related]
5. Capturing a reactive state of amyloid aggregates: NMR-based characterization of copper-bound Alzheimer disease amyloid β-fibrils in a redox cycle.
Parthasarathy S; Yoo B; McElheny D; Tay W; Ishii Y
J Biol Chem; 2014 Apr; 289(14):9998-10010. PubMed ID: 24523414
[TBL] [Abstract][Full Text] [Related]
6. Identifying, by first-principles simulations, Cu[amyloid-β] species making Fenton-type reactions in Alzheimer's disease.
La Penna G; Hureau C; Andreussi O; Faller P
J Phys Chem B; 2013 Dec; 117(51):16455-67. PubMed ID: 24313818
[TBL] [Abstract][Full Text] [Related]
7. RTHLVFFARK-NH
Meng J; Zhang H; Dong X; Liu F; Sun Y
J Inorg Biochem; 2018 Apr; 181():56-64. PubMed ID: 29407908
[TBL] [Abstract][Full Text] [Related]
8. How Zn can impede Cu detoxification by chelating agents in Alzheimer's disease: a proof-of-concept study.
Conte-Daban A; Day A; Faller P; Hureau C
Dalton Trans; 2016 Oct; 45(39):15671-15678. PubMed ID: 27711738
[TBL] [Abstract][Full Text] [Related]
9. Sulfur-bridging the gap: investigating the electrochemistry of novel copper chelating agents for Alzheimer's disease applications.
Crnich E; Sanchez E; Havens MA; Kissel DS
J Biol Inorg Chem; 2023 Oct; 28(7):643-653. PubMed ID: 37594567
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Aβ peptide aggregation by ruthenium(II) polypyridyl complexes through copper chelation.
Peng YB; Tao C; Tan CP; Zhao P
J Inorg Biochem; 2021 Nov; 224():111591. PubMed ID: 34450410
[TBL] [Abstract][Full Text] [Related]
11. Histidine availability is decisive in ROS-mediated cytotoxicity of copper complexes of Aβ1-16 peptide.
Ginotra YP; Ramteke SN; Walke GR; Rapole S; Kulkarni PP
Free Radic Res; 2016; 50(4):405-13. PubMed ID: 26690929
[TBL] [Abstract][Full Text] [Related]
12. Characterization of new specific copper chelators as potential drugs for the treatment of Alzheimer's disease.
Nguyen M; Robert A; Sournia-Saquet A; Vendier L; Meunier B
Chemistry; 2014 May; 20(22):6771-85. PubMed ID: 24797103
[TBL] [Abstract][Full Text] [Related]
13. Redox chemistry of copper-amyloid-beta: the generation of hydroxyl radical in the presence of ascorbate is linked to redox-potentials and aggregation state.
Guilloreau L; Combalbert S; Sournia-Saquet A; Mazarguil H; Faller P
Chembiochem; 2007 Jul; 8(11):1317-25. PubMed ID: 17577900
[TBL] [Abstract][Full Text] [Related]
14. Free Superoxide is an Intermediate in the Production of H2O2 by Copper(I)-Aβ Peptide and O2.
Reybier K; Ayala S; Alies B; Rodrigues JV; Bustos Rodriguez S; La Penna G; Collin F; Gomes CM; Hureau C; Faller P
Angew Chem Int Ed Engl; 2016 Jan; 55(3):1085-9. PubMed ID: 26629876
[TBL] [Abstract][Full Text] [Related]
15. Redox reactions of copper complexes formed with different beta-amyloid peptides and their neuropathological [correction of neuropathalogical] relevance.
Jiang D; Men L; Wang J; Zhang Y; Chickenyen S; Wang Y; Zhou F
Biochemistry; 2007 Aug; 46(32):9270-82. PubMed ID: 17636872
[TBL] [Abstract][Full Text] [Related]
16. Effect of metal chelators on the aggregation of beta-amyloid peptides in the presence of copper and iron.
Tahmasebinia F; Emadi S
Biometals; 2017 Apr; 30(2):285-293. PubMed ID: 28281098
[TBL] [Abstract][Full Text] [Related]
17. Specific Binding of Cu(II) Ions to Amyloid-Beta Peptides Bound to Aggregation-Inhibiting Molecules or SDS Micelles Creates Complexes that Generate Radical Oxygen Species.
Tiiman A; Luo J; Wallin C; Olsson L; Lindgren J; Jarvet J; Per R; Sholts SB; Rahimipour S; Abrahams JP; Karlström AE; Gräslund A; Wärmländer SK
J Alzheimers Dis; 2016 Oct; 54(3):971-982. PubMed ID: 27567855
[TBL] [Abstract][Full Text] [Related]
18. Hybrid Bis-Histidine Phenanthroline-Based Ligands to Lessen Aβ-Bound Cu ROS Production: An Illustration of Cu(I) Significance.
Drommi M; Rulmont C; Esmieu C; Hureau C
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946712
[TBL] [Abstract][Full Text] [Related]
19. 8-Hydroxyquinoline Schiff-base compounds as antioxidants and modulators of copper-mediated Aβ peptide aggregation.
Gomes LM; Vieira RP; Jones MR; Wang MC; Dyrager C; Souza-Fagundes EM; Da Silva JG; Storr T; Beraldo H
J Inorg Biochem; 2014 Oct; 139():106-16. PubMed ID: 25019963
[TBL] [Abstract][Full Text] [Related]
20. Reaction rates and mechanism of the ascorbic acid oxidation by molecular oxygen facilitated by Cu(II)-containing amyloid-beta complexes and aggregates.
Jiang D; Li X; Liu L; Yagnik GB; Zhou F
J Phys Chem B; 2010 Apr; 114(14):4896-903. PubMed ID: 20302320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
